Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Ondansetron for post-endoscopy nausea and vomiting in adults
IRCT20230926059530N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Oct 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone and ondansetron in nausea ((none)) and Vomiting (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Incidence of post-endoscopy nausea and Incidence of post-endoscopy vomiting. Started Oct 2023; status: completed.
02
Drugs
dexamethasoneondansetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on IRCT20230926059530N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230926059530N1.